170 related articles for article (PubMed ID: 32733821)
41. Local recurrence after microwave thermosphere ablation of malignant liver tumors: results of a surgical series.
Takahashi H; Kahramangil B; Berber E
Surgery; 2018 Apr; 163(4):709-713. PubMed ID: 29273176
[TBL] [Abstract][Full Text] [Related]
42. Actual 10-Year Survival After Surgical Microwave Ablation for Hepatocellular Carcinoma: A Single-Center Experience in Japan.
Ryu T; Takami Y; Wada Y; Hara T; Sasaki S; Saitsu H
Ann Surg Oncol; 2019 Nov; 26(12):4126-4133. PubMed ID: 31359277
[TBL] [Abstract][Full Text] [Related]
43. Analysis on efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma.
Yuan P; Zhang Z; Kuai J
J BUON; 2019; 24(1):163-170. PubMed ID: 30941966
[TBL] [Abstract][Full Text] [Related]
44. Percutaneous microwave ablation of exophytic tumours in hepatocellular carcinoma patients: Safe or not?
Ding J; Zhou Y; Wang Y; Jing X; Wang F; Wang Y
Liver Int; 2017 Sep; 37(9):1365-1372. PubMed ID: 28319345
[TBL] [Abstract][Full Text] [Related]
45. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cm.
Yan JY; Zhang JL; Wang MQ; Yuan K; Bai YH; Wang Y; Xin HN; Wang ZJ; Liu FY; Duan F; Fu JX
Asia Pac J Clin Oncol; 2018 Aug; 14(4):300-309. PubMed ID: 29124894
[TBL] [Abstract][Full Text] [Related]
46. Treatment efficacy of CT-guided percutaneous microwave ablation for primary hepatocellular carcinoma.
Yin T; Li W; Zhao P; Wang Y; Zheng J
Clin Radiol; 2017 Feb; 72(2):136-140. PubMed ID: 27890422
[TBL] [Abstract][Full Text] [Related]
47. Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas.
Zheng L; Li HL; Guo CY; Luo SX
Korean J Radiol; 2018; 19(2):237-246. PubMed ID: 29520181
[TBL] [Abstract][Full Text] [Related]
48. Surgical ablation of hepatocellular carcinoma with 2.45-GHz microwave: a critical appraisal of treatment outcomes.
Lee KF; Hui JW; Cheung YS; Wong JS; Chong CN; Wong J; Yu SC; Lai PB
Hong Kong Med J; 2012 Apr; 18(2):85-91. PubMed ID: 22477730
[TBL] [Abstract][Full Text] [Related]
49. [Evaluation of efficacy of liver cancer microwave ablation at 5 years postoperatively].
Zhao L; Zhuang DM; Hou XW; Wang GF; Zhang HW; Zhuang XX
Zhonghua Gan Zang Bing Za Zhi; 2019 Aug; 27(8):648-650. PubMed ID: 31594085
[TBL] [Abstract][Full Text] [Related]
50. Percutaneous Navigation under Local Anesthesia for Computed Tomography-Guided Microwave Ablation of Malignant Liver Lesions Located in the Hepatic Dome.
Filippiadis DK; Velonakis G; Mazioti A; Tsochatzis A; Vrachliotis T; Kelekis A; Kelekis N
Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684093
[No Abstract] [Full Text] [Related]
51. Ablation therapy of hepatocellular carcinoma: a comparative study between radiofrequency and microwave ablation.
Vogl TJ; Farshid P; Naguib NN; Zangos S; Bodelle B; Paul J; Mbalisike EC; Beeres M; Nour-Eldin NE
Abdom Imaging; 2015 Aug; 40(6):1829-37. PubMed ID: 25601438
[TBL] [Abstract][Full Text] [Related]
52. Safety and Efficacy of Percutaneous Microwave Hepatic Ablation Near the Heart.
Carberry GA; Smolock AR; Cristescu M; Wells SA; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Brace CL; Lee FT
J Vasc Interv Radiol; 2017 Apr; 28(4):490-497. PubMed ID: 28190707
[TBL] [Abstract][Full Text] [Related]
53. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI
Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
[TBL] [Abstract][Full Text] [Related]
54. [Therapy of malignant liver tumors using microwave and radiofrequency ablation].
Popescu I; Sîrbu-Boeţi MP; Tomulescu V; Ciurea S; Boroş M; Hrehoreţ D; Jemna C
Chirurgia (Bucur); 2005; 100(2):111-20. PubMed ID: 15957451
[TBL] [Abstract][Full Text] [Related]
55. Feasibility and safety of surgical microwave ablation for hepatocellular carcinoma in elderly patients: a single center analysis in Japan.
Imamura H; Takami Y; Ryu T; Wada Y; Sasaki S; Ureshino H; Saitsu H
Sci Rep; 2020 Aug; 10(1):14215. PubMed ID: 32848193
[TBL] [Abstract][Full Text] [Related]
56. Liver stiffness measurement changes following hepatocellular carcinoma treatment with percutaneous microwave ablation or transarterial chemoembolization: a cohort study.
Abdelaziz AO; Abdelhalim H; Elsharkawy A; Shousha HI; Abdelmaksoud AH; Soliman ZA; Seif MI; Sayed DB; Farouk MH; Elbaz TM; Nabeel MM
Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):685-691. PubMed ID: 30640743
[TBL] [Abstract][Full Text] [Related]
57. Combination Therapies in the Management of Large (≥ 5 cm) Hepatocellular Carcinoma: Microwave Ablation Immediately Followed by Transarterial Chemoembolization.
Si ZM; Wang GZ; Qian S; Qu XD; Yan ZP; Liu R; Wang JH
J Vasc Interv Radiol; 2016 Oct; 27(10):1577-83. PubMed ID: 27103146
[TBL] [Abstract][Full Text] [Related]
58. Ultrasound-guided percutaneous microwave ablation treatment of initial recurrent hepatocellular carcinoma after hepatic resection: long-term outcomes.
Zhang TT; Luo HC; Cui X; Zhang W; Zhang LY; Chen XP; Li KY
Ultrasound Med Biol; 2015 Sep; 41(9):2391-9. PubMed ID: 26074453
[TBL] [Abstract][Full Text] [Related]
59. High-powered microwave ablation of larger hepatocellular carcinoma: evaluation of recurrence rate and factors related to recurrence.
Zhang NN; Lu W; Cheng XJ; Liu JY; Zhou YH; Li F
Clin Radiol; 2015 Nov; 70(11):1237-43. PubMed ID: 26220125
[TBL] [Abstract][Full Text] [Related]
60. Magnetic resonance imaging-guided microwave ablation of hepatic malignancies: Feasibility, efficacy, safety, and follow-up.
Yang N; Gong J; Yao L; Wang C; Chen J; Liu J; Wang Z; Lu J
J Cancer Res Ther; 2020 Sep; 16(5):1151-1156. PubMed ID: 33004763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
